Patents-Review.com
ClassID:

21092 ⎘

A61K39/07 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies; Bacterial antigens Bacillus

Recent Application in this class:
#1
20260102478
2026-04-16

Vaccines and Antibodies for the Treatment and Prevention of Neurodegenerative Disorders and Inflammation Related Health Conditions

 #2
20250295748
2025-09-25

TREATMENT AND PREVENTION OF VIRAL INFECTIONS

 #3
20250276055
2025-09-04

Visco-elastic Solid Formulation for Oral Delivery of a Biologically Active Agent

 #4
20250275922
2025-09-04

THERMOSTABLE PARTICLE-BASED COMPOSITIONS AND MANUFACTURING PROCESS

 #5
20250262289
2025-08-21

BACILLUS SUBTILIS FLAGELLIN VARIANT AND USE THEREOF

 #6
20250186570
2025-06-12

ANTHRAX VACCINE

 #7
20250177534
2025-06-05

THERMOSTABLE UV INACTIVATED VACCINES AND OTHER BIOPHARMACEUTICALS

 #8
20250161437
2025-05-22

METHODS AND PARTICLES FOR MODULATING AN IMMUNE RESPONSE

 #9
20250152694
2025-05-15

METHODS AND COMPOSITIONS FOR MULTIVALENT VACCINES

 #10
20250152692
2025-05-15

IMMUNOGENS TARGETING ANTHRAX

 #11
20250101128
2025-03-27

CHIMERIC POLYPEPTIDE COMPOSITIONS AND ENCODING POLYNUCLEOTIDES THEREOF

 #12
20240398957
2024-12-05

ADDITIVES FOR PROTEIN FORMULATIONS TO IMPROVE THERMAL STABILITY

 #13
20240366755
2024-11-07

METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTICMICROBIAL THERAPEUTICS

 #14
20240358811
2024-10-31

POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE

 #15
20240316173
2024-09-26

COMPOSITIONS COMPRISING RECOMBINANT BACILLUS CELLS AND A FUNGICIDE

 #16
20240307519
2024-09-19

MICROENCAPSULATED STERNE VACCINE

 #17
20240285745
2024-08-29

COMPOSITIONS COMPRISING RECOMBINANT BACILLUS CELLS AND A FUNGICIDE

 #18
20240285744
2024-08-29

COMPOSITIONS COMPRISING RECOMBINANT BACILLUS CELLS AND AN INSECTICIDE

 #19
20240285743
2024-08-29

COMPOSITIONS COMPRISING RECOMBINANT BACILLUS CELLS AND AN INSECTICIDE

 #20
20240206466
2024-06-27

FUSION PROTEINS AND METHODS FOR STIMULATING PLANT GROWTH, PROTECTING PLANTS, AND IMMOBILIZING BACILLUS SPORES ON PLANTS

 #21
20240091332
2024-03-21

COMPOUNDS AND METHODS FOR BIOFILM DISRUPTION AND PREVENTION

 #22
20240058435
2024-02-22

SUSTAINED RELEASE INACTIVATED VACCINES

 #23
20230416694
2023-12-28

MODIFIED BACTERIOPHAGE

 #24
20230355804
2023-11-09

VIRUSES ENGINEERED TO PROMOTE THANOTRANSMISSION AND THEIR USE IN TREATING CANCER

 #25
20230248816
2023-08-10

PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE

 #26
20230241195
2023-08-03

MICROENCAPSULATED ORAL STERNE VACCINE

 #27
20230087802
2023-03-23

BACILLUS SUBTILIS JCK-1398 STRAIN INDUCING RESISTANCE IN VARIOUS PLANTS, AND COMPOSITION AND METHOD FOR CONTROLLING PINE WILT DISEASE BY USING SAME

 #28
20230083448
2023-03-16

COMPOSITIONS OF ALUM NANOPARTICLES FOR IMMUNOMODULATION AND METHODS FOR PRODUCING THE SAME

 #29
20230064184
2023-03-02

FOAM COMPOSITIONS FOR THE TREATMENT OF CANCER

 #30
20230036135
2023-02-02

BCG CAR CONSTRUCTS AND METHODS OF THEIR MANUFACTURE AND USE

 #31
20220409539
2022-12-29

PARTICLES FOR MULTI-DOSE DELIVERY

 #32
20220354943
2022-11-10

Therapeutic Agent Effectiveness and its Route of Adminstration

 #33
20220354940
2022-11-10

BEE VACCINES AND METHODS OF USE

 #34
20220288190
2022-09-15

PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE

 #35
20220265544
2022-08-25

TEETH CLEANING ANIMAL CHEW

 #36
20220159965
2022-05-26

Compositions comprising recombinant cells and a fungicide

 #37
20220151240
2022-05-19

Compositions comprising recombinant cells and an insecticide

 #38
20220001010
2022-01-06

ADJUVANTING SYSTEMS AND WATER-FREE VACCINE COMPOSITIONS COMPRISING A POLYI:C POLYNUCLEOTIDE ADJUVANT AND A LIPID-BASED ADJUVANT

 #39
20210379186
2021-12-09

ADDITIVES FOR PROTEIN FORMULATIONS TO IMPROVE THERMAL STABILITY

 #40
20210369840
2021-12-02

METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTIC MICROBIAL THERAPEUTICS

 #41
20210338793
2021-11-04

PLASMIDS AND METHODS FOR PEPTIDE DISPLAY AND AFFINITY-SELECTION ON VIRUS-LIKE PARTICLES OF RNA BACTERIOPHAGES

 #42
20210308252
2021-10-07

LIPOSOME COMPOSITIONS COMPRISING PAM2CYS OR PAM3CYS ADJUVANT AND METHODS FOR INDUCING A HUMORAL IMMUNE RESPONSE

 #43
20210290661
2021-09-23

IMMUNE MODIFYING PARTICLES FOR THE TREATMENT OF CANCER

 #44
20210260183
2021-08-26

Rapid and prolonged immunologic-therapeutic

 #45
20210252121
2021-08-19

REAGENTS AND METHODS FOR IDENTIFYING, ENRICHING, AND/OR EXPANDING ANTIGEN-SPECIFIC T CELLS

 #46
20210137124
2021-05-13

Fusion proteins and methods for stimulating plant growth, protecting plants, and immobilizing bacillus spores on plants

 #47
20210100248
2021-04-08

Mollusk-killing biopesticide

 #48
20210046126
2021-02-18

Composition having TCI711 and method for sobering up by using the same

 #49
20210015879
2021-01-21

Method for preserving probiotic composition and use thereof

 #50
20200338184
2020-10-29

Rapid and prolonged immunogic therapeutic

 #51
20200338183
2020-10-29

Rapid and prolonged immunologic therapeutic

 #52
20200315210
2020-10-08

Feed composition for preventing or treating acute hepatopancreatic necrosis disease (AHPND) or white spot syndrome (WSS), comprising a strain, a strain, and a strain as active ingredients

 #53
20200230057
2020-07-23

Pharmaceutical Compositions, Methods for Preparation using Lipid Vesicle Particles of Defined Size, and Uses Thereof

 #54
20200147207
2020-05-14

Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, bacillus anthracis and yersinia pestis

 #55
20200069744
2020-03-05

Combination probiotic compositions and uses thereof

 #56
20200048296
2020-02-13

and/or antigen

 #57
20190358272
2019-11-28

Preparation of dry formulations of dairy probiotics

 #58
20190307813
2019-10-10

Method and system for treating cancer and other age-related diseases by extending the healthspan of a human

 #59
20190240323
2019-08-08

Branched chimeric compounds, and methods of use thereof

 #60
20190240310
2019-08-08

Safe potent single platform vaccine against Tier 1 select agents and other pathogens

 #61
20190240307
2019-08-08

Synthetic immunogens for prophylaxis or treatment of tuberculosis

 #62
20190216841
2019-07-18

Regimens and Compositions for AAV-Mediated Passive Immunization of Airborne Pathogens

 #63
20190201492
2019-07-04

Immunomodulation after locoregional anti-tumoral treatment

 #64
20190142928
2019-05-16

Liposome compositions comprising PAM2Cys or PAM3Cys adjuvant and methods for inducing a humoral immune response

 #65
20190134178
2019-05-09

RAPID AND PROLONGED IMMUNOGENIC-THERAPEUTIC

 #66
20190119651
2019-04-25

Anti-bacterial compositions comparing lytic modified bacteriophage engineered to infect and kill different target bacteria

 #67
20190046630
2019-02-14

Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax

 #68
20180360954
2018-12-20

Linear chimeric compounds and methods of use thereof

 #69
20180360953
2018-12-20

METHODS TO IMPROVE INDUCTION OF IGG AND IGA ANTIBODIES BY VACCINES

 #70
20180339039
2018-11-29

Adjuvanting systems and water-free vaccine compositions comprising a polyI:C polynucleotide adjuvant and a lipid-based adjuvant

 #71
20180289012
2018-10-11

Mollusk-killing biopesticide

 #72
20180280534
2018-10-04

Methods and compositions for liposomal formulation of antigens and uses thereof

 #73
20180264102
2018-09-20

Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, and

#74
20180250377
2018-09-06

Bacillus based delivery system and methods of use

 #75
20180250376
2018-09-06

Modified anthrax toxin protective antigen

 #76
20180244731
2018-08-30

Compositions and methods for treatment of pain

 #77
20180169208
2018-06-21

Protective antigen complexes with increased stability and uses thereof

 #78
20180153980
2018-06-07

Inactivated Bacterial Cell Formulation

 #79
20180125966
2018-05-10

Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof

 #80
20180099043
2018-04-12

Methods to improve induction of IgA antibodies by vaccines

 #81
20180078631
2018-03-22

Synthetic immunogens for prophylaxis or treatment of tuberculosis

 #82
20180066225
2018-03-08

Method of preparing bacterial ghosts from gram-positive bacteria by hydrochloric acid treatment

 #83
20180064799
2018-03-08

Polypeptides and immunizing compositions containing polypeptides and methods of use

 #84
20180055925
2018-03-01

Display platform from bacterial spore coat proteins

 #85
20180028636
2018-02-01

METHODS AND COMPOSITIONS FOR EMERGENCY POST-INFECTION TREATMENT OF ANTHRAX

 #86
20180015156
2018-01-18

POLYMER PARTICLES AND USES THEREOF

 #87
20180009834
2018-01-11

ENTEROCOCCUS FAECALIS AND/OR ENTEROCOCCUS FAECIUM ANTIGEN

 #88
20170348359
2017-12-07

Method and system for treating cancer and other age-related diseases by extending the healthspan of a human

 #89
20170333544
2017-11-23

Multivalent stable vaccine composition and methods of making same

 #90
20170295797
2017-10-19

Compositions comprising recombinant cells and a fungicide

 #91
20170281545
2017-10-05

Immunomodulation using spores and pollen grains

 #92
20170253636
2017-09-07

Dual purpose universal influenza vaccine confers protective immunity against anthrax

 #93
20170246277
2017-08-31

Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cells

 #94
20170232092
2017-08-17

Methods and compositions for T cell generation and uses thereof

 #95
20170165344
2017-06-15

Serologic correlates of protection against infection

 #96
20170157266
2017-06-08

Methods and compositions for liposomal formulation of antigens and uses thereof

 #97
20170089901
2017-03-30

Treating bladder cancer patients and identifying bladder cancer patients responsive to treatment

 #98
20170087243
2017-03-30

COMPOSITIONS CONTAINING AMBIENT-TEMPERATURE STABLE, INACTIVATED BUT THERAPEUTICALLY ACTIVE BIOPHARMACEUTICALS & METHODS FOR FORMULATION THEREOF

 #99
20170058005
2017-03-02

VACCINE COMPOSITION COMPRISING ANTHRAX LETHAL FACTOR POLYPEPTIDE

 #100
20170007694
2017-01-12

METHODS AND COMPOSITIONS FOR THE STABILIZATION OF PROTEINS

 #101
20170007690
2017-01-12

METHODS AND COMPOSITIONS FOR THE STABILIZATION OF ANTHRAX RECOMBINANT PROTECTIVE ANTIGEN

 #102
20170007689
2017-01-12

Methods and compositions for nanoemulsion vaccine formulations

 #103
20170007682
2017-01-12

Multivalent stable vaccine composition and methods of making same

 #104
20170000872
2017-01-05

Inactivated bacterial cell formulation

 #105
20160324957
2016-11-10

Temperature stable vaccine formulations

 #106
20160317639
2016-11-03

USE OF BACTERIAL ENDOTOXINS AND LIPOTEICHOIC ACIDS TO IMPROVE POSTPARTAL HEALTH AND PRODUCTIVITY OF DAIRY COWS AND THEIR NEWBORNS

 #107
20160304567
2016-10-20

Methods and compositions for the display of polypeptides on the pili of Gram-positive bacteria

 #108
20160213774
2016-07-28

Branched and linear chimeric compounds, polynucleotides, uses and methods for preparation thereof

 #109
20160193317
2016-07-07

PROTECTIVE ANTIGEN COMPLEXES WITH INCREASED STABILITY AND USES THEREOF

 #110
20160160178
2016-06-09

IMMUNOTHERAPY USING STEM CELLS

 #111
20160137723
2016-05-19

Monoclonal antibodies that react with the capsule of

#112
20160136257
2016-05-19

Protein matrix vaccines and related methods of making and administering such vaccines

 #113
20160114020
2016-04-28

Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax

 #114
20160108371
2016-04-21

Recombinant vaccinia virus derived from KVAC103 strain

 #115
20160108096
2016-04-21

Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria

 #116
20160089430
2016-03-31

Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof

 #117
20160074495
2016-03-17

Inactivated bacterial cell formulation

 #118
20160058852
2016-03-03

IMMUNOTHERAPY OF CANCER THROUGH COMBINATION OF LOCAL AND SYSTEMIC IMMUNE STIMULATION

 #119
20160051656
2016-02-25

Bacillus based delivery system and methods of use

 #120
20160039874
2016-02-11

REGULATING BACILLUS ANTHRACIS LETHAL FACTOR ACTIVITY VIA AN ACTIVATING EPITOPE REGION

 #121
20160022801
2016-01-28

Rodent hepadnavirus cores with reduced carrier-specific antigenicity

 #122
20160022797
2016-01-28

Rapid and prolonged immunologic-therapeutic

 #123
20160022796
2016-01-28

Synthetic immunogens for prophylaxis or treatment of tuberculosis

 #124
20150343047
2015-12-03

COMPOSITIONS AND METHODS FOR TREATMENT OF CERVICAL DYSPLASIA

 #125
20150335752
2015-11-26

Temperature Stable Vaccine Formulations

 #126
20150297750
2015-10-22

THERAPEUTIC AND VACCINE POLYELECTROLYTE NANOPARTICLE COMPOSITIONS

 #127
20150283069
2015-10-08

Inhalable vaccine compositions and methods

 #128
20150266933
2015-09-24

Compositions and methods for vaccination

 #129
20150265691
2015-09-24

Anthrose-based compositions and related methods

 #130
20150250832
2015-09-10

Bacterial composition for the treatment of colibacillosis on farms, in particular poultry farms, and also drinking water containing such a bacterial composition

 #131
20150246108
2015-09-03

Serologic correlates of protection against infection

 #132
20150240245
2015-08-27

Human optimized protective antigen

 #133
20150224184
2015-08-13

Engineered anthrax lethal toxin for targeted delivery

 #134
20150216974
2015-08-06

Compositions And Methods Of Modulating The Immune Response

 #135
20150196628
2015-07-16

Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers

 #136
20150165016
2015-06-18

POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE

 #137
20150093412
2015-04-02

USE OF SACCHARIDES CROSS-REACTIVE WITH BACILLUS ANTHRACIS SPORE GLYCOPROTEIN AS A VACCINE AGAINST ANTHRAX

 #138
20150079133
2015-03-19

Method of vaccine delivery via microneedle arrays

 #139
20150050318
2015-02-19

MULTIVALENT NANOEMULSION VACCINES

 #140
20150050312
2015-02-19

Bacterial vaccine

 #141
20150050292
2015-02-19

Detection, prevention, and treatment of anthrax and other infectious diseases

 #142
20150033410
2015-01-29

Methods and compositions for emergency post-infection treatment of anthrax

 #143
20150023998
2015-01-22

Stable Anthrax Vaccine Formulations

 #144
20140322265
2014-10-30

Recombinant poxvirus vector comprising tetanus toxin fragment C

 #145
20140315863
2014-10-23

Treating bladder cancer patients and identifying bladder cancer patients responsive to treatment

 #146
20140308341
2014-10-16

Methods and compositions for liposomal formulation of antigens and uses thereof

 #147
20140302120
2014-10-09

Conjugates of synthetic TLR agonists and uses therefor

 #148
20140294895
2014-10-02

Expression of Protective Antigens in Transgenic Chloroplasts and the Production of Improved Vaccines

 #149
20140294894
2014-10-02

TRANSCUTANEOUS DELIVERY OF THERAPEUTIC AGENTS

 #150
20140234404
2014-08-21

Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof

 #151
20140186399
2014-07-03

Protein matrix vaccines and methods of making and administering such vaccines

 #152
20140170188
2014-06-19

HtrA-defective-derived vaccines

 #153
20140141041
2014-05-22

Rapid and prolonged immunologic-therapeutic

 #154
20140141031
2014-05-22

Pathogenic bacteria

 #155
20140105961
2014-04-17

Immunomodulation using spores and pollen grains

 #156
20140099314
2014-04-10

polypeptide and antibodies

 #157
20140086989
2014-03-27

Protein matrix vaccine compositions including polycations

 #158
20140056958
2014-02-27

APPARATUS, SYSTEM, AND METHOD FOR CREATING BIOLOGICALLY PROTECTED/ENHANCED SPACES IN VIVO

 #159
20140050764
2014-02-20

Inactivated bacterial cell formulation

 #160
20140004150
2014-01-02

Vaccine injection, preparation method and use thereof

 #161
20130287810
2013-10-31

VACCINE COMPOSITIONS AND USES THEREOF

 #162
20130287787
2013-10-31

Monoclonal antibodies that react with the capsule of

#163
20130273101
2013-10-17

Vaccine for inducing an improved immune reaction

 #164
20130189308
2013-07-25

EXPRESSION OF PROTECTIVE ANTIGENS IN TRANSGENIC CHLOROPLASTS AND THE PRODUCTION OF IMPROVED VACCINES

 #165
20130156807
2013-06-20

Conjugates of synthetic TLR agonists and uses therefor

 #166
20130156728
2013-06-20

COMPOSITION FOR NEUROLOGICAL OR AUTOIMMUNE DISEASES

 #167
20130149330
2013-06-13

PHARMACEUTICAL COMPOSITIONS AND METHODS OF BLOCKING BACILLUS ANTHRACIS

 #168
20130122106
2013-05-16

DOSAGE FORM, AND METHODS OF MAKING AND USING THE SAME, TO PRODUCE IMMUNIZATION IN ANIMALS AND HUMANS

 #169
20130115237
2013-05-09

THERAPEUTIC IMMUNIZATION IN HIV INFECTED SUBJECTS TO AUGMENT ANTIRETROVIRAL TREATMENT

 #170
20130058969
2013-03-07

Chloroplasts engineered to express pharmaceutical proteins

 #171
20130052250
2013-02-28

Compounds and methods for biofilm disruption and prevention

 #172
20130011439
2013-01-10

Inactivated bacterial cell formulation

 #173
20120308597
2012-12-06

Serologic correlates of protection against infection

 #174
20120301466
2012-11-29

CHEMICALLY PROGRAMMABLE IMMUNITY

 #175
20120295813
2012-11-22

Plasmids and methods for peptide display and affinity-selection on virus-like particles of RNA bacteriophages

 #176
20120282701
2012-11-08

DNA promoters and anthrax vaccines

 #177
20120276138
2012-11-01

Rapid and prolonged immunologic-therapeutic

 #178
20120269839
2012-10-25

HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

 #179
20120258137
2012-10-11

IMMUNOGENIC COMPOSITIONS COMPRISING NANOEMULSION AND HEPATITIS B VIRUS IMMUNOGEN AND METHODS OF USING THE SAME

 #180
20120237544
2012-09-20

Bacterial spore having therapeutic agent adsorbed on its surface

 #181
20120231086
2012-09-13

PROTEIN MATRIX VACCINES OF IMPROVED IMMUNOGENICITY

 #182
20120201846
2012-08-09

POLYMER PARTICLES AND USES THEREOF

 #183
20120201782
2012-08-09

Peptide, adjuvants, vaccines, and methods of use

 #184
20120171214
2012-07-05

polypeptides and antibodies

 #185
20120156237
2012-06-21

Antitoxin and vaccine platform based on nodavirus VLPS

 #186
20120149095
2012-06-14

DNA promoters and anthrax vaccines

 #187
20120148660
2012-06-14

Conjugates of synthetic TLR agonists and uses therefor

 #188
20120148621
2012-06-14

Methods and compositions for promoting a cell-mediated immune response

 #189
20120141526
2012-06-07

Nanoemulsion vaccines

 #190
20120135038
2012-05-31

EXPRESSION OF PROTECTIVE ANTIGENS IN TRANSGENIC CHLOROPLASTS AND THE PRODUCTION OF IMPROVED VACCINES

 #191
20120107349
2012-05-03

Multivalent nanoemulsion vaccines

 #192
20120039946
2012-02-16

Immunopotentiating composition and process for producing same

 #193
20120021004
2012-01-26

Medium and method of deriving and using a mutated bacteria strain

 #194
20110312877
2011-12-22

ENGINEERED TUNABLE NANOPARTICLES FOR DELIVERY OF THERAPEUTICS, DIAGNOSTICS, AND EXPERIMENTAL COMPOUNDS AND RELATED COMPOSITIONS FOR THERAPEUTIC USE

 #195
20110281316
2011-11-17

based delivery system and methods of use

 #196
20110280899
2011-11-17

Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopes

 #197
20110256172
2011-10-20

EPITOPE-TARGETED ANTHRAX VACCINE

 #198
20110236425
2011-09-29

Anthrax vaccine formulation and uses thereof

 #199
20110229507
2011-09-22

Stable anthrax vaccine formulations

 #200
20110223163
2011-09-15

Monoclonal antibodies that react with the capsule of

#201
20110201092
2011-08-18

attenuated for entry into non-phagocytic cells, vaccines comprising the and methods of use thereof

 #202
20110189236
2011-08-04

Methods and Compositions for the Display of Polypeptides on the Pili of Gram-Positive Bacteria

 #203
20110171223
2011-07-14

Anti-peptide antibodies that cross react with protective antigen of and uses thereof

 #204
20110159047
2011-06-30

STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES

 #205
20110142881
2011-06-16

Transcutaneous delivery of therapeutic agents

 #206
20110142870
2011-06-16

antigens, vaccine compositions, and related methods

 #207
20110135679
2011-06-09

Compositions for inducing immune responses

 #208
20110123564
2011-05-26

Adenoviral-based vectors

 #209
20110110968
2011-05-12

Human optimized Bacillus anthracis protective antigen

 #210
20110110954
2011-05-12

Anthrax compositions and methods of use and production

 #211
20110104293
2011-05-05

SYNERGISTIC INDUCTION OF HUMORAL AND CELLULAR IMMUNITY BY COMBINATORIAL ACTIVATION OF TOLL-LIKE RECEPTORS

 #212
20110091493
2011-04-21

VACCINE COMPOSITIONS AND USES THEREOF

 #213
20110091465
2011-04-21

polypeptides and antibodies

 #214
20110064723
2011-03-17

Formulation for room temperature stabilization of a live attenuated bacterial vaccine

 #215
20110052628
2011-03-03

Recombinant Double-Stranded RNA Phage, and Use of the Same

 #216
20110014235
2011-01-20

Therapeutic and vaccine polyelectrolyte nanoparticle compositions

 #217
20110014184
2011-01-20

Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions

 #218
20100330074
2010-12-30

USE OF SACCHARIDES CROSS-REACTIVE WITH BACILLUS ANTHRACIS SPORE GLYCOPROTEIN AS A VACCINE AGAINST ANTHRAX

 #219
20100297092
2010-11-25

Inactivated bacterial cell formulation

 #220
20100291152
2010-11-18

Chemically modified peptides with improved immunogenicity

 #221
20100247535
2010-09-30

Chemically programmable immunity

 #222
20100233174
2010-09-16

Anthrax carbohydrates, synthesis and uses thereof

 #223
20100233124
2010-09-16

based delivery system and methods of use

 #224
20100226973
2010-09-09

Methods and compositions for liposomal formulation of antigens and uses thereof

 #225
20100226941
2010-09-09

Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides

 #226
20100196451
2010-08-05

Vaccines Containing Non-Live Antigenic Vectors

 #227
20100183675
2010-07-22

Stable vaccine compositions and methods of use

 #228
20100172926
2010-07-08

Anthrax compositions and methods of use and production

 #229
20100150965
2010-06-17

DNA promoters and anthrax vaccines

 #230
20100068230
2010-03-18

Modified free-living microbes, vaccine compositions and methods of use thereof

 #231
20100055123
2010-03-04

VACCINE AGAINST BURKHOLDERIA INFECTIONS

 #232
20100055112
2010-03-04

and/or antigen

 #233
20100028433
2010-02-04

Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same

 #234
20100021488
2010-01-28

HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

 #235
20100015181
2010-01-21

Vaccine formulation

 #236
20100008950
2010-01-14

COMPOSITION AND METHOD FOR THE INDUCTION OF IMMUNITY AGAINST BACILLUS CEREUS GROUP BACTERIA

 #237
20100003276
2010-01-07

Methods for treating anthrax and inhibiting lethal factor

 #238
20090305398
2009-12-10

Recombinant double stranded RNA nucleocapsid and use of the same

 #239
20090297556
2009-12-03

based oral vaccines for anthrax

 #240
20090297548
2009-12-03

IMMUNOGENIC COMPOSITIONS COMPRISING ANTHRAX SPORE-ASSOCIATED PROTEINS

 #241
20090291095
2009-11-26

NANOEMULSION ADJUVANTS

 #242
20090246200
2009-10-01

Anthrax carbohydrates, synthesis and uses thereof

 #243
20090246193
2009-10-01

Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions

 #244
20090155330
2009-06-18

Vaccine delivery via microneedle arrays

 #245
20090155299
2009-06-18

Antibodies for the detection of and vaccine against infections

 #246
20090110700
2009-04-30

ACELLULAR IMMUNOGENIC COMPOSITIONS AND ACELLULAR VACCINE COMPOSITIONS AGAINST BACILLUS ANTHRACIS

 #247
20090010998
2009-01-08

Drug-delivery patch comprising a dissolvable layer and uses thereof

 #248
20080317784
2008-12-25

Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant

 #249
20080311147
2008-12-18

Rhabdoviral N-Fusion Proteins as Carrier for Foreign Antigens

 #250
20080311108
2008-12-18

polypeptides

 #251
20080299148
2008-12-04

Antitoxin and vaccine platform based on nodavirus VLPs

 #252
20080274143
2008-11-06

Chloroplasts Engineering to Express Pharmaceutical Proteins

 #253
20080254066
2008-10-16

Nanoemulsion Vaccines

 #254
20080248066
2008-10-09

Modified free-living microbes, vaccine compositions and methods of use thereof

 #255
20080233181
2008-09-25

NANOPARTICLE ADJUVANTS FOR SUB-UNIT VACCINES

 #256
20080226729
2008-09-18

STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES

 #257
20080219960
2008-09-11

Novel Efficient Production Process for Capsular Polysaccharides of Pathogenic Grampositive Bacteria by Heterologous Expression and Secretion of Complex Polysaccharides in Non-Pathogenic, Non-Invasive Gram-Positive Bacteria

 #258
20080181949
2008-07-31

Nanoemulsion Vaccines

 #259
20080181905
2008-07-31

Nanoemulsion Vaccines

 #260
20080159984
2008-07-03

Compositions capable of facilitating penetration across a biological barrier

 #261
20080138431
2008-06-12

Pharmaceutical Composition

 #262
20080095803
2008-04-24

Protein matrix vaccines and methods of making and administering such vaccines

 #263
20070237782
2007-10-11

Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae

 #264
20070224206
2007-09-27

Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions

 #265
20070202130
2007-08-30

Anthrax antigens and methods of use

 #266
20070202117
2007-08-30

Compositions and Methods Of Modulating the Immune Response

 #267
20070160631
2007-07-12

Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes

 #268
20070154494
2007-07-05

Anthrax vaccines and delivery methods

 #269
20070148188
2007-06-28

Anthrax vaccine

 #270
20070128213
2007-06-07

Novel plant virus particles and methods of inactivation thereof

 #271
20070105799
2007-05-10

Codon-optimized polynucleotide-based vaccines against Bacillus anthracis infection

 #272
20070087986
2007-04-19

Compositions and methods for enhancing immunity by chemoattractant adjuvants

 #273
20070031457
2007-02-08

Modified Bacillus anthracis, vaccine compositions and methods of use thereof

 #274
20060269570
2006-11-30

Recombinant double-stranded RNA phage, and use of the same

 #275
20060263389
2006-11-23

Methods and compositions to enhance immune responses via recall antigens

 #276
20060257426
2006-11-16

Nanoemulsion vaccines

 #277
20060204525
2006-09-14

Compositions and methods for preventing and treating anthrax diseases

 #278
20060147418
2006-07-06

Recombinant double-stranded RNA phages and uses thereof

 #279
20060134143
2006-06-22

Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli

 #280
20060099228
2006-05-11

Acellular immunogenic compositions and acellular vaccine compositions against

#281
20060088514
2006-04-27

Formulation comprising a bacterial strain

 #282
20060019380
2006-01-26

Genetic vaccines directed against bacterial exotoxins

 #283
20060019239
2006-01-26

Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides

 #284
20050271689
2005-12-08

Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax

 #285
20050260601
2005-11-24

Recombinant mutants of rhabdovirus and methods of use thereof

 #286
20050260293
2005-11-24

Biocontrol for plants with bacillus subtilis, pseudomonas putida, and sporobolomyces roseus

 #287
20050234004
2005-10-20

Compositions and methods of use of W-peptides

 #288
20050232981
2005-10-20

Compositions capable of facilitating penetration across a biological barrier

 #289
20050226892
2005-10-13

Methods and compositions comprising bacteriophage nanoparticles

 #290
20050175630
2005-08-11

Immunogenic compositions and methods of use thereof

 #291
20050158346
2005-07-21

Antimultiorganism glycoconjugate vaccine

 #292
20050148529
2005-07-07

Nucleic acid immunization

 #293
20050112145
2005-05-26

Anthrax antigenic compositions

 #294
20050108792
2005-05-19

Expression of protective antigens in transgenic chloroplasts

 #295
14695445
2019-05-21

Pharmaceutical compositions and methods of blocking

#296
14321315
2016-11-08

Immunization and/or treatment of parasites and infectious agents by live bacteria